Results 111 to 120 of about 78,818 (344)

Novel [99mTcN]2+ Labeled EGFR Inhibitors as Potential Radiotracers for Single Photon Emission Computed Tomography (SPECT) Tumor Imaging

open access: yesMolecules, 2014
The epidermal growth factor receptor (EGFR) is overexpressed in many cancers, including breast, ovarian, endometrial and non-small cell lung cancer. An EGFR-specific imaging agent could facilitate clinical evaluation of primary tumors or metastases.
Mingxia Zhao   +5 more
doaj   +1 more source

Highlighting the versatility of the Tracerlab synthesis modules. Part 2: fully automated production of [ 11 C]‐labeled radiopharmaceuticals using a Tracerlab FX C‐Pro [PDF]

open access: yes, 2011
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/89445/1/jlcr1937 ...
Arai   +139 more
core   +1 more source

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review

open access: yesJournal of Clinical Medicine, 2019
Background: Bacterial infections are still one of the main factors associated with mortality worldwide. Many radiopharmaceuticals were developed for bacterial imaging, both with single photon emission computed tomography (SPECT) and positron emission ...
S. Auletta   +5 more
semanticscholar   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller   +5 more
wiley   +1 more source

Moral NIMBY-ism? Understanding Societal Support for Monetary Compensation to Plasma Donors in Canada [PDF]

open access: yes, 2018
The growing demand for plasma, especially for the manufacture of therapeutic products, prompts discussions on the merits of different procurement systems.
Lacetera, Nicola, Macis, Mario
core   +2 more sources

ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals

open access: yesAnnals of the ICRP, 2019
: Radiopharmaceuticals are increasingly used for the treatment of various cancers with novel radionuclides, compounds, tracer molecules, and administration techniques.
Y. Yonekura   +11 more
semanticscholar   +1 more source

Radiopharmaceuticals in Acute Porphyria

open access: yesClinical Therapeutics, 2016
The acute porphyrias are a group of rare metabolic disorders of the heme biosynthetic pathway. Carriers of the acute porphyria gene are prone to potentially fatal acute attacks, which can be precipitated by drug exposure. It is therefore important to know whether a drug is safe for carriers of the acute porphyria gene.
Nanno Schreuder   +2 more
openaire   +3 more sources

2D van der Waals System Integrated with Targeting Radio‐Diagnostic and Imaging Functions

open access: yesSmall, EarlyView.
Layered double hydroxide (LDH) nanoplates were engineered for tumor‐targeted imaging and therapy. By exploiting folate receptor (FR) expression levels, the system achieves selective tumor accumulation and high‐resolution dual PET/fluorescence (PET/FL) imaging.
Sairan Eom   +6 more
wiley   +1 more source

Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With 18F-Fluorocholine Dual Time Point PET/MRI. [PDF]

open access: yes, 2017
Recent technical advances in positron emission tomography/magnetic resonance imaging (PET/MRI) technology allow much improved time-of-flight (TOF) and regularized iterative PET reconstruction regularized iterative reconstruction (RIR) algorithms.
Behr, Spencer C   +5 more
core   +1 more source

Preparation and frst biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P [PDF]

open access: yes, 2014
Introduction: New 188Re and 99mTc peptide conjugates with substance- P (SP) were prepared and biologically evaluated. The radiopharmaceuticals have been labelled with the [M=N]2+ (M=99mTc, 188Re) core using a combination of pi-donor tridentate and pi ...
Katarina Smilkov   +32 more
core   +1 more source

Home - About - Disclaimer - Privacy